Lysosomes are organelles central to degradation and recycling processes in animal cells. Whether lysosomal activity is coordinated to respond to cellular needs remains unclear. We found that most lysosomal genes exhibit coordinated transcriptional behavior and are regulated by the transcription factor EB (TFEB). Under aberrant lysosomal storage conditions, TFEB translocated from the cytoplasm to the nucleus, resulting in the activation of its target genes. TFEB overexpression in cultured cells induced lysosomal biogenesis and increased the degradation of complex molecules, such as glycosaminoglycans and the pathogenic protein that causes Huntington's disease. Thus, a genetic program controls lysosomal biogenesis and function, providing a potential therapeutic target to enhance cellular clearing in lysosomal storage disorders and neurodegenerative diseases.
A Gene Network Regulating Lysosomal Biogenesis and Function / Sardiello, M; Palmieri, M; di Ronza, A; Medina, Dl; Valenza, M; Gennarino, Va; Di Malta, C; Donaudy, F; Embrione, V; Polishchuk, Rs; Banfi, S; Parenti, G; Cattaneo, E; Ballabio, A. - In: SCIENCE. - ISSN 0036-8075. - ELETTRONICO. - 325:(2009), pp. 473-477.
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello M;Medina DL;Di Malta C;Parenti G;Ballabio A
2009
Abstract
Lysosomes are organelles central to degradation and recycling processes in animal cells. Whether lysosomal activity is coordinated to respond to cellular needs remains unclear. We found that most lysosomal genes exhibit coordinated transcriptional behavior and are regulated by the transcription factor EB (TFEB). Under aberrant lysosomal storage conditions, TFEB translocated from the cytoplasm to the nucleus, resulting in the activation of its target genes. TFEB overexpression in cultured cells induced lysosomal biogenesis and increased the degradation of complex molecules, such as glycosaminoglycans and the pathogenic protein that causes Huntington's disease. Thus, a genetic program controls lysosomal biogenesis and function, providing a potential therapeutic target to enhance cellular clearing in lysosomal storage disorders and neurodegenerative diseases.File | Dimensione | Formato | |
---|---|---|---|
Science_Express_Sardiello.pdf
non disponibili
Tipologia:
Abstract
Licenza:
Accesso privato/ristretto
Dimensione
1.02 MB
Formato
Adobe PDF
|
1.02 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.